Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 143109, 24 pages
http://dx.doi.org/10.1155/2015/143109
Review Article

Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence

1Division of Medicine, Department of Hepatology, Gastroenterology and Metabolism, Rudolf-Virchow-Hospital, Charité University Medicine, 13353 Berlin, Germany
2Lipid Clinic, Experimental and Clinical Research Center (ECRC), Max-Delbrück-Center for Molecular Medicine and Charité University Medicine, 13353 Berlin, Germany
3Institute of General Pathology, Catholic University School of Medicine, 00168 Rome, Italy
4The Synergistic Innovation Center for Food Safety and Nutrition, State Key Laboratory of Food Science and Technology, and School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China
5Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
6Department of Physiology, National Taiwan University College of Medicine, Taipei 100, Taiwan
7Department of Biochemistry, School of Medicine, Cancer Research Institute, Infection Signaling Network Research Center, Chungnam National University, Daejeon 301-747, Republic of Korea
8Research Center for Biotechnology Applied to Cosmetology, Catholic University School of Medicine, 00168 Rome, Italy

Received 21 January 2015; Revised 18 May 2015; Accepted 28 May 2015

Academic Editor: Sabine Rohrmann

Copyright © 2015 Karsten H. Weylandt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. S. Harris, T. D. Dayspring, and T. J. Moran, “Omega-3 fatty acids and cardiovascular disease: new developments and applications,” Postgraduate Medicine, vol. 125, no. 6, pp. 100–113, 2013. View at Google Scholar · View at Scopus
  2. D. Kromhout and J. de Goede, “Update on cardiometabolic health effects of ω-3 fatty acids,” Current Opinion in Lipidology, vol. 25, no. 1, pp. 85–90, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Calviello, S. Serini, and E. Piccioni, “Alzheimer's disease and n-3 polyunsaturated fatty acids: beneficial effects and possible molecular pathways involved,” Current Signal Transduction Therapy, vol. 3, no. 3, pp. 152–157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. I. F. Janssen and A. J. Kiliaan, “Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration,” Progress in Lipid Research, vol. 53, no. 1, pp. 1–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Young and J. Conquer, “Omega-3 fatty acids and neuropsychiatric disorders,” Reproduction Nutrition Development, vol. 45, no. 1, pp. 1–28, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. M. Ortega, E. Rodríguez-Rodríguez, and A. M. López-Sobaler, “Effects of omega 3 fatty acids supplementation in behavior and non-neurodegenerative neuropsychiatric disorders,” British Journal of Nutrition, vol. 107, supplement 2, pp. S261–S270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. P. C. Calder, “Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1851, no. 4, pp. 469–484, 2015. View at Publisher · View at Google Scholar
  8. G. Calviello, S. Serini, and E. Piccioni, “n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved,” Current Medicinal Chemistry, vol. 14, no. 29, pp. 3059–3069, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Bougnoux, N. Hajjaji, K. Maheo, C. Couet, and S. Chevalier, “Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth,” Progress in Lipid Research, vol. 49, no. 1, pp. 76–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Gu, J. Suburu, H. Chen, and Y. Q. Chen, “Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention,” BioMed Research International, vol. 2013, Article ID 824563, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. E. K. J. Pauwels and M. Kostkiewicz, “Fatty acid facts, part III: cardiovascular disease, or, a fish diet is not fishy,” Drug News and Perspectives, vol. 21, no. 10, pp. 552–561, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. G. P. Eckert, U. Lipka, and W. E. Muller, “Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 88, no. 1, pp. 105–114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. X. Kang and K. H. Weylandt, “Modulation of inflammatory cytokines by omega-3 fatty acids,” Sub-Cellular Biochemistry, vol. 49, pp. 133–143, 2008. View at Google Scholar · View at Scopus
  14. T. A. Babcock, T. Dekoj, and N. J. Espat, “Experimental studies defining omega-3 fatty acid antiinflammatory mechanisms and abrogation of tumor-related syndromes,” Nutrition in Clinical Practice, vol. 20, no. 1, pp. 62–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Calviello, S. Serini, and P. Palozza, “n-3 Polyunsaturated fatty acids as signal transduction modulators and therapeutical agents in cancer,” Current Signal Transduction Therapy, vol. 1, no. 3, pp. 255–271, 2006. View at Publisher · View at Google Scholar
  16. C. Boudrault, R. P. Bazinet, and D. W. L. Ma, “Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease,” Journal of Nutritional Biochemistry, vol. 20, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Liperoti, F. Landi, O. Fusco, R. Bernabei, and G. Onder, “Omega-3 polyunsaturated fatty acids and depression: a review of the evidence,” Current Pharmaceutical Design, vol. 15, no. 36, pp. 4165–4172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico), “Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico,” The Lancet, vol. 354, no. 9177, pp. 447–455, 1999. View at Google Scholar
  19. P. Vitello, Alexander Leaf Dies at 92; Linked Diet and Health, New York Times, 2013.
  20. G. De Maria, “Omega-3. An overview. Focus on omega-3,” Agro Food Industry Hi-Tech, vol. 19, supplement, pp. 4–9, 2008. View at Google Scholar
  21. D. Kromhout, E. J. Giltay, and J. M. Geleijnse, “n-3 fatty acids and cardiovascular events after myocardial infarction,” The New England Journal of Medicine, vol. 363, no. 21, pp. 2015–2026, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. M. Kwak, S.-K. Myung, Y. J. Lee, and H. G. Seo, “Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials,” Archives of Internal Medicine, vol. 172, no. 9, pp. 686–694, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Bosch, H. C. Gerstein, G. R. Dagenais et al., “n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia,” The New England Journal of Medicine, vol. 367, no. 4, pp. 309–318, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. G. Fodor, E. Helis, N. Yazdekhasti, and B. Vohnout, “‘Fishing’ for the origins of the ‘Eskimos and heart disease’ story: facts or wishful thinking?” Canadian Journal of Cardiology, vol. 30, no. 8, pp. 864–868, 2014. View at Publisher · View at Google Scholar
  25. T. M. Brasky, A. K. Darke, X. Song et al., “Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial,” Journal of the National Cancer Institute, vol. 105, no. 15, pp. 1132–1141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Serini, E. Fasano, E. Piccioni, A. R. M. Cittadini, and G. Calviello, “Dietary n-3 polyunsaturated fatty acids and the paradox of their health benefits and potential harmful effects,” Chemical Research in Toxicology, vol. 24, no. 12, pp. 2093–2105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Suburu, K. Lim, G. Calviello, and Y. Q. Chen, “RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial,” Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju023, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. R. T. Holman, S. B. Johnson, and T. F. Hatch, “A case of human linolenic acid deficiency involving neurological abnormalities,” The American Journal of Clinical Nutrition, vol. 35, no. 3, pp. 617–623, 1982. View at Google Scholar · View at Scopus
  29. L. M. Arterburn, E. B. Hall, and H. Oken, “Distribution, interconversion, and dose response of n-3 fatty acids in humans,” American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1467S–1476S, 2006. View at Google Scholar · View at Scopus
  30. A. H. Stark, M. A. Crawford, and R. Reifen, “Update on alpha-linolenic acid,” Nutrition Reviews, vol. 66, no. 6, pp. 326–332, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Jing, T. Wu, and K. Lim, “Omega-3 polyunsaturated fatty acids and cancer,” Anti-Cancer Agents in Medicinal Chemistry, vol. 13, no. 8, pp. 1162–1177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. G. C. Burdge, “Metabolism of α-linolenic acid in humans,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 75, no. 3, pp. 161–168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. R. T. Holman, “The slow discovery of the importance of ω3 essential fatty acids in human health,” The Journal of Nutrition, vol. 128, no. 2, supplement, pp. 427S–433S, 1998. View at Google Scholar · View at Scopus
  34. S. A. Scholtz, J. Colombo, and S. E. Carlson, “Clinical overview of effects of dietary long-chain polyunsaturated fatty acids during the perinatal period,” Nestlè Nutrition Institute Workshop Series, vol. 77, pp. 145–154, 2013. View at Google Scholar · View at Scopus
  35. E. N. Smit, F. A. J. Muskiet, and E. R. Boersma, “The possible role of essential fatty acids in the pathophysiology of malnutrition: a review,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 71, no. 4, pp. 241–250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. D. F. Horrobin, “Essential fatty acid metabolism and its modification in atopic eczema,” The American Journal of Clinical Nutrition, vol. 71, supplement 1, pp. 367S–372S, 2000. View at Google Scholar · View at Scopus
  37. A. P. Simopoulos, “Human requirement for N-3 polyunsaturated fatty acids,” Poultry Science, vol. 79, no. 7, pp. 961–970, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. FAO-WHO, Fats and Fatty Acids in Human Nutrition: Report of an Expert Consultation, FAO Food and Nutrition Paper # 91, FAO, WHO, Geneva, Switzerland, 2010.
  39. International Society for the Study of Fatty Acids and Lipids (ISSFAL), Report of the Sub-Committee on: Recommendations for Intake of Polyunsaturated Fatty Acids in Healthy Adults, International Society for the Study of Fatty Acids and Lipids (ISSFAL), 2004.
  40. A. F. Luzzi and W. P. T. James, “European diet and public health: the continuing challenge,” Public Health Nutrition, vol. 4, no. 2A, pp. 275–292, 2001. View at Google Scholar · View at Scopus
  41. B. Koletzko, E. Lien, C. Agostoni et al., “The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations,” Journal of Perinatal Medicine, vol. 36, no. 1, pp. 5–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. EFSA Panel on Dietetic Products; Nutrition and Allergies (NDA), “Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol,” The EFSA Journal, vol. 8, no. 3, article 1461, 2010. View at Publisher · View at Google Scholar
  43. The Scientific Advisory Committee on Nutrition and Committee on Toxicity Advice on Benefits and Risks Related to Fish Consumption, SACN Advice on Fish Consumption: Benefits and Risks, The Scientific Advisory Committee on Nutrition and Committee on Toxicity Advice on Benefits and Risks Related to Fish Consumption, 2004.
  44. Health Council of the Netherlands, Guidelines for a Healthy Diet 2006, Publication no. 2006/21E, Health Council of the Netherlands, The Hague, the Netherlands, 2006.
  45. Health Council of the Netherlands, Dietary Reference Intakes: Energy, Proteins, Fats, and Digestible Carbohydrates, Health Council of the Netherlands, The Hague, The Netherlands, 2001, (Corrected Edition: June 2002).
  46. AFSSA, Apports nutritionnels conseillés pour la population française, Tec & Doc Lavoisier Editions, 3rd edition, 2001.
  47. Conseil Supérieur de la Santé, Recommandations nutritionnelles pour la Belgique, Revision 2009, Publication du Conseil Superieur de la Sante no. 8 8309, Conseil Supérieur de la Santé, Brussels, Belgium, 2009.
  48. Sociedad Española de Nutrición Comunitaria (SENC), “Objetivos nutricionales para la población española,” Revista Española de Nutrición Comunitaria, vol. 17, no. 4, pp. 178–199, 2011. View at Google Scholar
  49. National Health and Medical Research Council and Department of Health and Ageing, Nutrient Reference Values for Australia and New Zealand Including Recommended Dietary Intakes, Commonwealth of Australia, Canberra, Australia, 2006.
  50. Institute of Medicine, Food and Nutrition Board, Panel on Macronutrients, Panel on the Definition of Dietary Fiber, Subcommittee on Upper Reference Levels of Nutrients, Subcommittee on Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, DRI Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids, Washington, DC, USA, The National Academies Press, 2005.
  51. J. P. Bantle, J. Wylie-Rosett, and A. L. Albright, “Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association,” Diabetes Care, vol. 31, supplement 1, pp. S61–S78, 2007. View at Publisher · View at Google Scholar
  52. P. M. Kris-Etherton, S. Innis, Ammerican Dietetic Assocition, and Dietitians of Canada, “Position of the American dietetic association and dietitians of Canada: dietary fatty acids,” The Journal of the American Dietetic Association, vol. 107, no. 9, pp. 1599–1611, 2007. View at Google Scholar · View at Scopus
  53. W. S. Harris, D. Mozaffarian, E. Rimm et al., “Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention,” Circulation, vol. 119, no. 6, pp. 902–907, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Leaf, C. M. Albert, M. Josephson et al., “Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake,” Circulation, vol. 112, no. 18, pp. 2762–2768, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Tavazzi, A. P. Maggioni, R. Marchioli et al., “Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial,” The Lancet, vol. 372, no. 9645, pp. 1223–1230, 2008. View at Publisher · View at Google Scholar
  56. P. Galan, E. Kesse-Guyot, S. Czernichow et al., “Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial,” The British Medical Journal, vol. 341, Article ID c6273, 2010. View at Publisher · View at Google Scholar
  57. M. Yokoyama, H. Origasa, M. Matsuzaki et al., “Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis,” The Lancet, vol. 369, no. 9567, pp. 1090–1098, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Rauch, R. Schiele, S. Schneider et al., “OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction,” Circulation, vol. 122, no. 21, pp. 2152–2159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. M. H. Raitt, W. E. Connor, C. Morris et al., “Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial,” The Journal of the American Medical Association, vol. 293, no. 23, pp. 2884–2891, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. I. A. Brouwer, P. L. Zock, A. J. Camm et al., “Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty acids and ventricular Arrhythmia (SOFA) randomized trial,” The Journal of the American Medical Association, vol. 295, no. 22, pp. 2613–2619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Chowdhury, S. Warnakula, S. Kunutsor et al., “Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis,” Annals of Internal Medicine, vol. 160, no. 6, pp. 398–406, 2014. View at Google Scholar · View at Scopus
  62. E. C. Rizos, E. E. Ntzani, E. Bika, M. S. Kostapanos, and M. S. Elisaf, “Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis,” The Journal of the American Medical Association, vol. 308, no. 10, pp. 1024–1033, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Belluzzi, C. Brignola, M. Campieri, A. Pera, S. Boschi, and M. Miglioli, “Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease,” The New England Journal of Medicine, vol. 334, no. 24, pp. 1557–1560, 1996. View at Publisher · View at Google Scholar · View at Scopus
  64. E. Scorletti, L. Bhatia, K. G. McCormick et al., “Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome study,” Hepatology, vol. 60, no. 4, pp. 1211–1221, 2014. View at Google Scholar
  65. B. G. Feagan, W. J. Sandborn, U. Mittmann et al., “Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC randomized controlled trials,” Journal of the American Medical Association, vol. 299, no. 14, pp. 1690–1697, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. W. F. Stenson, D. Cort, J. Rodgers et al., “Dietary supplementation with fish oil in ulcerative colitis,” Annals of Internal Medicine, vol. 116, no. 8, pp. 609–614, 1992. View at Publisher · View at Google Scholar · View at Scopus
  67. N. Lasztity, J. Hamvas, L. Biró et al., “Effect of enterally administered n-3 polyunsaturated fatty acids in acute pancreatitis—a prospective randomized clinical trial,” Clinical Nutrition, vol. 24, no. 2, pp. 198–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Cabré, M. Mañosa, and M. A. Gassull, “Omega-3 fatty acids and inflammatory bowel diseases-a systematic review,” British Journal of Nutrition, vol. 107, no. 2, pp. S240–S252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Dyerberg, H. O. Bang, E. Stoffersen, S. Moncada, and J. R. Vane, “Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?” The Lancet, vol. 2, no. 8081, pp. 117–119, 1978. View at Publisher · View at Google Scholar · View at Scopus
  70. J. X. Kang and A. Leaf, “Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 21, pp. 9886–9890, 1994. View at Publisher · View at Google Scholar · View at Scopus
  71. K. H. Weylandt, J. X. Kang, and A. Leaf, “Polyunsaturated fatty acids exert antiarrhythmic actions as free acids rather than in phospholipids,” Lipids, vol. 31, no. 9, pp. 977–982, 1996. View at Publisher · View at Google Scholar · View at Scopus
  72. G. E. Billman, J. X. Kang, and A. Leaf, “Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs,” Lipids, vol. 32, no. 11, pp. 1161–1168, 1997. View at Publisher · View at Google Scholar · View at Scopus
  73. P. M. Kris-Etherton, W. S. Harris, and L. J. Appel, “Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease,” Circulation, vol. 106, no. 21, pp. 2747–2757, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. G. Taubes, “The science of obesity: what do we really know about what makes us fat? An essay by Gary Taubes,” British Medical Journal, vol. 346, no. 7904, Article ID f1050, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. W. S. Harris and G. C. Shearer, “Omega-6 fatty acids and cardiovascular disease: friend or foe?” Circulation, 2014. View at Publisher · View at Google Scholar
  76. M. de Lorgeril, P. Salen, P. Defaye, and M. Rabaeus, “Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?” BMC Medicine, vol. 11, no. 1, article 5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. W. S. Harris and C. von Schacky, “The Omega-3 Index: a new risk factor for death from coronary heart disease?” Preventive Medicine, vol. 39, no. 1, pp. 212–220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. W. S. Harris, “The omega-3 index as a risk factor for coronary heart disease,” The American Journal of Clinical Nutrition, vol. 87, no. 6, pp. 1997S–2002S, 2008. View at Google Scholar · View at Scopus
  79. R. Fischer, A. Konkel, H. Mehling et al., “Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway,” The Journal of Lipid Research, vol. 55, no. 6, pp. 1150–1164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. K. H. Weylandt, C.-Y. Chiu, B. Gomolka, S. F. Waechter, and B. Wiedenmann, “Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation,” Prostaglandins & Other Lipid Mediators, vol. 97, no. 3-4, pp. 73–82, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. J. R. Falck, G. Wallukat, N. Puli et al., “17(R),18(S)-Epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues,” Journal of Medicinal Chemistry, vol. 54, no. 12, pp. 4109–4118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. J. Endo, M. Sano, Y. Isobe et al., “18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling,” Journal of Experimental Medicine, vol. 211, no. 8, pp. 1673–1687, 2014. View at Publisher · View at Google Scholar
  83. M. Anti, G. Marra, F. Armelao et al., “Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer,” Gastroenterology, vol. 103, no. 3, pp. 883–891, 1992. View at Google Scholar · View at Scopus
  84. H.-P. Bartram, A. Gostner, W. Scheppach et al., “Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects,” Gastroenterology, vol. 105, no. 5, pp. 1317–1322, 1993. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Anti, F. Armelao, G. Marra et al., “Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas,” Gastroenterology, vol. 107, no. 6, pp. 1709–1718, 1994. View at Google Scholar · View at Scopus
  86. H.-P. Bartram, A. Gostner, B. S. Reddy et al., “Missing anti-proliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high-fat diet: potential role of the n-3:n-6 fatty acid ratio,” European Journal of Cancer Prevention, vol. 4, no. 3, pp. 231–237, 1995. View at Publisher · View at Google Scholar · View at Scopus
  87. Y.-C. Huang, J. M. Jessup, R. A. Forse et al., “n-3 Fatty acids decrease colonic epithelial cell proliferation in high-risk bowel mucosa,” Lipids, vol. 31, no. 3, supplement, pp. S313–S317, 1996. View at Publisher · View at Google Scholar · View at Scopus
  88. J. M. Gee, M. Watson, J. A. Matthew et al., “Consumption of fish oil leads to prompt incorporation of eicosapentaenoic acid into colonic mucosa of patients prior to surgery for colorectal cancer, but has no detectable effect on epithelial cytokinetics,” The Journal of Nutrition, vol. 129, no. 10, pp. 1862–1865, 1999. View at Google Scholar · View at Scopus
  89. J. Cheng, K. Ogawa, K. Kuriki et al., “Increased intake of n-3 polyunsaturated fatty acids elevates the level of apoptosis in the normal sigmoid colon of patients polypectomized for adenomas/tumors,” Cancer Letters, vol. 193, no. 1, pp. 17–24, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. E. D. Courtney, S. Matthews, C. Finlayson et al., “Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas,” International Journal of Colorectal Disease, vol. 22, no. 7, pp. 765–776, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. N. J. West, S. K. Clark, R. K. S. Phillips et al., “Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis,” Gut, vol. 59, no. 7, pp. 918–925, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. A. J. Cockbain, M. Volpato, A. D. Race et al., “Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid,” Gut, vol. 63, no. 11, pp. 1760–1768, 2014. View at Publisher · View at Google Scholar · View at Scopus
  93. G. K. Pot, G. Majsak-Newman, A. Geelen et al., “Fish consumption and markers of colorectal cancer risk: a multicenter randomized controlled trial,” The American Journal of Clinical Nutrition, vol. 90, no. 2, pp. 354–361, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. G. K. Pot, A. Geelen, G. Majsak-Newman et al., “Increased consumption of fatty and lean fish reduces serum C-reactive protein concentrations but not inflammation markers in feces and in colonic biopsies,” Journal of Nutrition, vol. 140, no. 2, pp. 371–376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. M. C. Mocellin, J. D. A. Pastore E Silva, C. D. Q. Camargo et al., “Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients,” Lipids, vol. 48, no. 9, pp. 879–888, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. H. J. Murff, M. J. Shrubsole, Q. Cai et al., “Dietary intake of PUFAs and colorectal polyp risk,” The American Journal of Clinical Nutrition, vol. 95, no. 3, pp. 703–712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. E. D. Kantor, J. W. Lampe, U. Peters, T. L. Vaughan, and E. White, “Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer,” Nutrition and Cancer, vol. 66, no. 4, pp. 716–727, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Song, A. T. Chan, C. S. Fuchs et al., “Dietary intake of fish, ω-3 and ω-6 fatty acids and risk of colorectal cancer: a prospective study in U.S. men and women,” International Journal of Cancer, vol. 135, no. 10, pp. 2413–2423, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. N. Habermann, C. M. Ulrich, A. Lundgreen et al., “PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer,” Genes and Nutrition, vol. 8, no. 1, pp. 115–126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Wu, B. Feng, K. Li et al., “Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis,” The American Journal of Medicine, vol. 125, no. 6, pp. 551–559, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Gerber, “Background review paper on total fat, fatty acid intake and cancers,” Annals of Nutrition and Metabolism, vol. 55, no. 1–3, pp. 140–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Gerber, “Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies,” British Journal of Nutrition, vol. 107, no. 2, pp. S228–S239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  103. K. Mina, L. Fritschi, K. C. Johnson et al., “An inverse association between preserved fish and prostate cancer: results from a population-based case-control study in Canada,” Nutrition and Cancer, vol. 60, no. 2, pp. 222–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. C. D. Williams, B. M. Whitley, C. Hoyo et al., “A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer,” Nutrition Research, vol. 31, no. 1, pp. 1–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. F. L. Crowe, N. E. Allen, P. N. Appleby et al., “Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition,” The American Journal of Clinical Nutrition, vol. 88, no. 5, pp. 1353–1363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. V. Fradet, L. Cheng, G. Casey, and J. S. Witte, “Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk,” Clinical Cancer Research, vol. 15, no. 7, pp. 2559–2566, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. A. R. Kristal, J. H. Cohen, P. Qu, and J. L. Stanford, “Associations of energy, fat, calcium, and vitamin D with prostate cancer risk,” Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 8, pp. 719–725, 2002. View at Google Scholar · View at Scopus
  108. J. E. Chavarro, M. J. Stampfer, M. N. Hall, H. D. Sesso, and J. Ma, “A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality,” The American Journal of Clinical Nutrition, vol. 88, no. 5, pp. 1297–1303, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. S.-Y. Park, L. R. Wilkens, S. M. Henning et al., “Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort,” Cancer Causes and Control, vol. 20, no. 2, pp. 211–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. J. E. Torfadottir, U. A. Valdimarsdottir, L. A. Mucci et al., “Consumption of fish products across the lifespan and prostate cancer risk,” PLoS ONE, vol. 8, no. 4, Article ID e59799, 2013. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Männistö, P. Pietinen, M. J. Virtanen et al., “Fatty acids and risk of prostate cancer in a nested case-control study in male smokers,” Cancer Epidemiology, Biomarkers and Prevention, vol. 12, no. 12, pp. 1422–1428, 2003. View at Google Scholar · View at Scopus
  112. M. E. Chua, M. C. D. Sio, M. C. Sorongon, and M. L. Morales Jr., “The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: a meta-analysis,” Canadian Urological Association Journal, vol. 7, no. 5-6, pp. E333–E343, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. M. K. Sorongon-Legaspi, M. Chua, M. C. Sio, and M. Morales, “Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer,” Prostate Cancer, vol. 2013, Article ID 875615, 15 pages, 2013. View at Publisher · View at Google Scholar
  114. D. Patel, K. Thevenet-Morrison, and E. van Wijngaarden, “Omega-3 polyunsaturated fatty acid intake through fish consumption and prostate specific antigen level: results from the 2003 to 2010 national health and examination survey,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 91, no. 4, pp. 155–160, 2014. View at Publisher · View at Google Scholar
  115. S. Harvei, K. S. Bjerve, S. Tretli, E. Jellum, T. E. Robsahm, and L. Vatten, “Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer,” International Journal of Cancer, vol. 71, no. 4, pp. 545–551, 1997. View at Google Scholar · View at Scopus
  116. K. M. Szymanski, D. C. Wheeler, and L. A. Mucci, “Fish consumption and prostate cancer risk: a review and meta-analysis,” The American Journal of Clinical Nutrition, vol. 92, no. 5, pp. 1223–1233, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. I. A. Brouwer, “Omega-3 PUFA: good or bad for prostate cancer?” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 79, no. 3–5, pp. 97–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. B. Samuelsson, “Prostaglandins, thromboxanes, and leukotrienes: formation and biological roles,” Harvey Lectures, vol. 75, pp. 1–40, 1979. View at Google Scholar · View at Scopus
  119. S. Moncada, S. H. Ferreira, and J. R. Vane, “Prostaglandins, aspirin like drugs and the oedema of inflammation,” Nature, vol. 246, no. 5430, pp. 217–219, 1973. View at Google Scholar · View at Scopus
  120. B. Gopinath, A. E. Buyken, V. M. Flood, M. Empson, E. Rochtchina, and P. Mitchell, “Consumption of polyunsaturated fatty acids, fish, and nuts and risk of inflammatory disease mortality,” The American Journal of Clinical Nutrition, vol. 93, no. 5, pp. 1073–1079, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. H. F. Turk, J. M. Monk, Y.-Y. Fan, E. S. Callaway, B. Weeks, and R. S. Chapkin, “Inhibitory effects of omega-3 fatty acids on injury-induced epidermal growth factor receptor transactivation contribute to delayed wound healing,” American Journal of Physiology—Cell Physiology, vol. 304, no. 9, pp. C905–C917, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. C. V. Whiting, P. W. Bland, and J. F. Tarlton, “Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis,” Inflammatory Bowel Diseases, vol. 11, no. 4, pp. 340–349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  123. S. Ghosh, D. DeCoffe, K. Brown et al., “Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis,” PLoS ONE, vol. 8, no. 2, Article ID e55468, 2013. View at Publisher · View at Google Scholar · View at Scopus
  124. F. G. Campos, D. L. Waitzberg, A. Habr-Gama et al., “Impact of parenteral n-3 fatty acids on experimental acute colitis,” British Journal of Nutrition, vol. 87, no. 1, pp. S83–S88, 2002. View at Publisher · View at Google Scholar · View at Scopus
  125. J. I. Fenton, N. G. Hord, S. Ghosh, and E. A. Gurzell, “Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 89, no. 6, pp. 379–390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. H. Matsunaga, R. Hokari, C. Kurihara et al., “Omega-3 fatty acids exacerbate DSS-induced colitis through decreased adiponectin in colonic subepithelial myofibroblasts,” Inflammatory Bowel Diseases, vol. 14, no. 10, pp. 1348–1357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. H. L. Woodworth, S. J. McCaskey, D. M. Duriancik et al., “Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis,” Cancer Research, vol. 70, no. 20, pp. 7960–7969, 2010. View at Publisher · View at Google Scholar · View at Scopus
  128. R. A. F. Hegazi, R. S. Saad, H. Mady, L. E. Matarese, S. O'Keefe, and H. M. Kandil, “Dietary fatty acids modulate chronic colitis, colitis-associated colon neoplasia and COX-2 expression in IL-10 knockout mice,” Nutrition, vol. 22, no. 3, pp. 275–282, 2006. View at Publisher · View at Google Scholar · View at Scopus
  129. R. Kühn, J. Löhler, D. Rennick, K. Rajewsky, and W. Müller, “Interleukin-10-deficient mice develop chronic enterocolitis,” Cell, vol. 75, no. 2, pp. 263–274, 1993. View at Publisher · View at Google Scholar · View at Scopus
  130. R. S. Chapkin, L. A. Davidson, L. Ly, B. R. Weeks, J. R. Lupton, and D. N. McMurray, “Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer,” Journal of Nutrition, vol. 137, supplement 1, pp. 200S–204S, 2007. View at Google Scholar · View at Scopus
  131. J. X. Kang, J. Wang, L. Wu, and Z. B. Kang, “Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids,” Nature, vol. 427, no. 6974, p. 504, 2004. View at Google Scholar · View at Scopus
  132. C. A. Hudert, K. H. Weylandt, Y. Lu et al., “Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 30, pp. 11276–11281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  133. J. M. Monk, Q. Jia, E. Callaway et al., “Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in fat-1 mice,” Journal of Nutrition, vol. 142, no. 1, pp. 117–124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  134. Q. Jia, J. R. Lupton, R. Smith et al., “Reduced colitis-associated colon cancer in fat-1 (n-3 fatty acid desaturase) transgenic mice,” Cancer Research, vol. 68, no. 10, pp. 3985–3991, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. J. Nowak, K. H. Weylandt, P. Habbel et al., “Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids,” Carcinogenesis, vol. 28, no. 9, pp. 1991–1995, 2007. View at Publisher · View at Google Scholar · View at Scopus
  136. C. Schmöcker, K. H. Weylandt, L. Kahlke et al., “Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines,” Hepatology, vol. 45, no. 4, pp. 864–869, 2007. View at Publisher · View at Google Scholar · View at Scopus
  137. K. H. Weylandt, A. Nadolny, L. Kahlke et al., “Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis,” Biochimica et Biophysica Acta - Molecular Basis of Disease, vol. 1782, no. 11, pp. 634–641, 2008. View at Publisher · View at Google Scholar · View at Scopus
  138. H. Teague, C. J. Fhaner, M. Harris, D. M. Duriancik, G. E. Reid, and S. R. Shaikh, “N-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity,” Journal of Lipid Research, vol. 54, no. 11, pp. 3130–3138, 2013. View at Publisher · View at Google Scholar · View at Scopus
  139. C. N. Serhan, S. Hong, K. Gronert et al., “Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals,” The Journal of Experimental Medicine, vol. 196, no. 8, pp. 1025–1037, 2002. View at Publisher · View at Google Scholar · View at Scopus
  140. M. Arita, F. Bianchini, J. Aliberti et al., “Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1,” The Journal of Experimental Medicine, vol. 201, no. 5, pp. 713–722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  141. C. Y. Chiu, B. Gomolka, C. Dierkes et al., “Omega-6 docosapentaenoic acid-derived resolvins and 17- hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis,” Inflammation Research, vol. 61, no. 9, pp. 967–976, 2012. View at Publisher · View at Google Scholar · View at Scopus
  142. T. Köhnke, B. Gomolka, S. Bilal et al., “Acetylsalicylic acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators,” BioMed Research International, vol. 2013, Article ID 748160, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  143. K. H. Weylandt, L. F. Krause, B. Gomolka et al., “Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-α,” Carcinogenesis, vol. 32, no. 6, pp. 897–903, 2011. View at Publisher · View at Google Scholar · View at Scopus
  144. A. F. Bento, R. F. Claudino, R. C. Dutra, R. Marcon, and J. B. Calixto, “Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice,” Journal of Immunology, vol. 187, no. 4, pp. 1957–1969, 2011. View at Publisher · View at Google Scholar · View at Scopus
  145. A. González-Périz, A. Planagumà, K. Gronert et al., “Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA,” The FASEB Journal, vol. 20, no. 14, pp. 2537–2539, 2006. View at Publisher · View at Google Scholar · View at Scopus
  146. A. Neuhofer, M. Zeyda, D. Mascher et al., “Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation,” Diabetes, vol. 62, no. 6, pp. 1945–1956, 2013. View at Publisher · View at Google Scholar · View at Scopus
  147. A. Ariel and C. N. Serhan, “Resolvins and protectins in the termination program of acute inflammation,” Trends in Immunology, vol. 28, no. 4, pp. 176–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  148. J. Griffitts, D. Saunders, Y. A. Tesiram et al., “Non-mammalian fat-1 gene prevents neoplasia when introduced to a mouse hepatocarcinogenesis model. Omega-3 fatty acids prevent liver neoplasia,” Biochimica et Biophysica Acta, vol. 1801, no. 10, pp. 1133–1144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  149. K. Lim, C. Han, Y. Dai, M. Shen, and T. Wu, “Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2,” Molecular Cancer Therapeutics, vol. 8, no. 11, pp. 3046–3055, 2009. View at Publisher · View at Google Scholar · View at Scopus
  150. N. Sawada, M. Inoue, M. Iwasaki et al., “Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma,” Gastroenterology, vol. 142, no. 7, pp. 1468–1475, 2012. View at Publisher · View at Google Scholar · View at Scopus
  151. J. A. Baron, B. F. Cole, R. S. Sandler et al., “A randomized trial of aspirin to prevent colorectal adenomas,” The New England Journal of Medicine, vol. 348, no. 10, pp. 891–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  152. P. M. Rothwell, M. Wilson, C. E. Elwin et al., “Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials,” The Lancet, vol. 376, no. 9754, pp. 1741–1750, 2010. View at Publisher · View at Google Scholar · View at Scopus
  153. M. A. Hull, A. C. Sandell, A. A. Montgomery et al., “A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial,” Trials, vol. 14, no. 1, article 237, 2013. View at Publisher · View at Google Scholar · View at Scopus
  154. S. Serini, E. Piccioni, and G. Calviello, “ω-3 PUFAs and colon cancer: experimental studies and human interventional trials,” in Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer, G. Calviello and S. Serini, Eds., vol. 1 of Diet and Cancer, pp. 67–89, Springer, Dordrecht, The Netherlands, 2010. View at Publisher · View at Google Scholar
  155. S. Serini, E. Fasano, E. Piccioni, A. R. M. Cittadini, and G. Calviello, “Differential anti-cancer effects of purified EPA and DHA and possible mechanisms involved,” Current Medicinal Chemistry, vol. 18, no. 26, pp. 4065–4075, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. S. Serini, E. Fasano, L. Celleno, A. Cittadini, and G. Calviello, “Potential of long-chain n-3 polyunsaturated fatty acids in melanoma prevention,” Nutrition Reviews, vol. 72, no. 4, pp. 255–266, 2014. View at Publisher · View at Google Scholar · View at Scopus
  157. K. Triff, E. Kim, and R. S. Chapkin, “Chemoprotective epigenetic mechanisms in a colorectal cancer model: modulation by n-3 PUFA in combination with fermentable fiber,” Current Pharmacology Reports, vol. 1, no. 1, pp. 11–20, 2015. View at Publisher · View at Google Scholar
  158. R. S. Chapkin, J. Seo, D. N. McMurray, and J. R. Lupton, “Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine,” Chemistry and Physics of Lipids, vol. 153, no. 1, pp. 14–23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  159. R. S. Chapkin, V. DeClercq, E. Kim, N. R. Fuentes, and Y. Y. Fan, “Mechanisms by which pleiotropic amphiphilic n-3 PUFA reduce colon cancer risk,” Current Colorectal Cancer Reports, vol. 10, no. 4, pp. 442–452, 2014. View at Publisher · View at Google Scholar
  160. W. Stillwell and S. R. Wassall, “Docosahexaenoic acid: membrane properties of a unique fatty acid,” Chemistry and Physics of Lipids, vol. 126, no. 1, pp. 1–27, 2003. View at Publisher · View at Google Scholar · View at Scopus
  161. E. Fasano, S. Serini, E. Piccioni et al., “DHA induces apoptosis by altering the expression and cellular location of GRP78 in colon cancer cell lines,” Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1822, no. 11, pp. 1762–1772, 2012. View at Publisher · View at Google Scholar · View at Scopus
  162. M. Ni, Y. Zhang, and A. S. Lee, “Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting,” Biochemical Journal, vol. 434, no. 2, pp. 181–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  163. R. A. Siddiqui, K. Harvey, and W. Stillwell, “Anticancer properties of oxidation products of docosahexaenoic acid,” Chemistry and Physics of Lipids, vol. 153, no. 1, pp. 47–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  164. D.-S. Im, “Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs,” Progress in Lipid Research, vol. 51, no. 3, pp. 232–237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  165. P. C. Calder, “Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance,” Biochimica et Biophysica Acta, vol. 1851, no. 4, pp. 469–484, 2015. View at Publisher · View at Google Scholar
  166. N. Sadli, M. L. Ackland, D. de Mel, A. J. Sinclair, and C. Suphioglu, “Effects of zinc and DHA on the epigenetic regulation of human neuronal cells,” Cellular Physiology and Biochemistry, vol. 29, no. 1-2, pp. 87–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  167. H.-S. Lee, A. Barraza-Villarreal, H. Hernandez-Vargas et al., “Modulation of DNA methylation states and infant immune system by dietary supplementation with ω-3 PUFA during pregnancy in an intervention study,” The American Journal of Clinical Nutrition, vol. 98, no. 2, pp. 480–487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  168. M. Amarasekera, P. Noakes, D. Strickland, R. Saffery, D. J. Martino, and S. L. Prescott, “Epigenome-wide analysis of neonatal CD4+ T-cell DNA methylation sites potentially affected by maternal fish oil supplementation,” Epigenetics, vol. 9, no. 12, pp. 1570–1576, 2014. View at Publisher · View at Google Scholar
  169. M. Dimri, P. V. Bommi, A. A. Sahasrabuddhe, J. D. Khandekar, and G. P. Dimri, “Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells,” Carcinogenesis, vol. 31, no. 3, pp. 489–495, 2010. View at Publisher · View at Google Scholar · View at Scopus
  170. Y. Cho, N. D. Turner, L. A. Davidson, R. S. Chapkin, R. J. Carroll, and J. R. Lupton, “A chemoprotective fish oil/pectin diet enhances apoptosis via Bcl-2 promoter methylation in rat azoxymethane-induced carcinomas,” Experimental Biology and Medicine, vol. 237, no. 12, pp. 1387–1393, 2012. View at Publisher · View at Google Scholar · View at Scopus
  171. Y. Cho, N. D. Turner, L. A. Davidson, R. S. Chapkin, R. J. Carroll, and J. R. Lupton, “Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation,” Experimental Biology and Medicine, vol. 239, no. 3, pp. 302–310, 2014. View at Publisher · View at Google Scholar
  172. A. J. Cockbain, G. J. Toogood, and M. A. Hull, “Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer,” Gut, vol. 61, no. 1, pp. 135–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  173. A. Bommareddy, X. Zhang, D. Schrader et al., “Effects of dietary flaxseed on intestinal tumorigenesis in ApcMin mouse,” Nutrition and Cancer, vol. 61, no. 2, pp. 276–283, 2009. View at Publisher · View at Google Scholar · View at Scopus
  174. G. Piazzi, G. D'Argenio, A. Prossomariti et al., “Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota,” International Journal of Cancer, vol. 135, no. 9, pp. 2004–2013, 2014. View at Publisher · View at Google Scholar · View at Scopus
  175. P. Griffini, O. Fehres, L. Klieverik et al., “Dietary omega-3 polyunsaturated fatty acids promote colon carcinoma metastasis in rat liver,” Cancer Research, vol. 58, no. 15, pp. 3312–3319, 1998. View at Google Scholar
  176. T. Yang, S. Fang, H.-X. Zhang et al., “N-3 PUFAs have antiproliferative and apoptotic effects on human colorectal cancer stem-like cells in vitro,” Journal of Nutritional Biochemistry, vol. 24, no. 5, pp. 744–753, 2013. View at Publisher · View at Google Scholar · View at Scopus
  177. F. de Carlo, T. R. Witte, W. E. Hardman, and P. P. Claudio, “Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy,” PLoS ONE, vol. 8, no. 7, Article ID e69760, 2013. View at Publisher · View at Google Scholar · View at Scopus
  178. A. Vasudevan, Y. Yu, S. Banerjee et al., “Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer,” Cancer Prevention Research, vol. 7, no. 11, pp. 1138–1148, 2014. View at Publisher · View at Google Scholar
  179. A. Zeuner, M. Todaro, G. Stassi, and R. De Maria, “Colorectal cancer stem cells: from the crypt to the clinic,” Cell Stem Cell, vol. 15, no. 6, pp. 692–705, 2014. View at Publisher · View at Google Scholar
  180. N. Barker, J. H. van Es, J. Kuipers et al., “Identification of stem cells in small intestine and colon by marker gene Lgr5,” Nature, vol. 449, no. 7165, pp. 1003–1007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  181. P. Dalerba, S. J. Dylla, I. K. Park et al., “Phenotypic characterization of human colorectal cancer stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 24, pp. 10158–10163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  182. L. Ricci-Vitiani, D. G. Lombardi, E. Pilozzi et al., “Identification and expansion of human colon-cancer-initiating cells,” Nature, vol. 445, no. 7123, pp. 111–115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  183. P. D. Biondo, D. N. Brindley, M. B. Sawyer, and C. J. Field, “The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy,” Journal of Nutritional Biochemistry, vol. 19, no. 12, pp. 787–796, 2008. View at Publisher · View at Google Scholar · View at Scopus
  184. G. Calviello, S. Serini, E. Piccioni, and G. Pessina, “Antineoplastic effects of N-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies,” Nutrition and Cancer, vol. 61, no. 3, pp. 287–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  185. J. Wang, T. Luo, S. Li, and J. Zhao, “The powerful applications of polyunsaturated fatty acids in improving the therapeutic efficacy of anticancer drugs,” Expert Opinion on Drug Delivery, vol. 9, no. 1, pp. 1–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  186. G. Calviello, P. Palozza, P. Franceschelli, and G. M. Bartoli, “Low-dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues,” Lipids, vol. 32, no. 10, pp. 1075–1083, 1997. View at Publisher · View at Google Scholar · View at Scopus
  187. S. S. Taneja, “Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial,” The Journal of Urology, vol. 191, no. 3, p. 658, 2014. View at Google Scholar · View at Scopus
  188. K. El-Bayoumy, H. Thompson, and A. Manni, “RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial,” Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju017, 2014. View at Publisher · View at Google Scholar · View at Scopus
  189. J. T. Brenna, G. C. Burdge, M. A. Crawford et al., “RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial,” Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju015, 2014. View at Publisher · View at Google Scholar · View at Scopus
  190. M. McCulloch, E. Alvarez, R. Gendreau, S. Haney, J. Harrelson, and R. Luo, “RE: serum phospholipid fatty acids and prostate cancer risk in the SELECT trial,” Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju024, 2014. View at Publisher · View at Google Scholar · View at Scopus
  191. W. S. Harris and M. H. Davidson, “RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial,” Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju019, 2014. View at Publisher · View at Google Scholar · View at Scopus
  192. J. E. Torfadottir, M. J. Stampfer, L. A. Mucci, and E. L. Giovannucci, “RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial,” Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju018, 2014. View at Publisher · View at Google Scholar · View at Scopus
  193. M. F. McCarty, J. J. Dinicolantonio, C. J. Lavie, and J. H. O'Keefe, “RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial,” Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju014, 2014. View at Publisher · View at Google Scholar · View at Scopus
  194. L. G. Cleland, S. M. Proudman, and M. J. James, “RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial,” Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju022, 2014. View at Publisher · View at Google Scholar · View at Scopus
  195. S. Tokudome, R. Ando, Y. Ichikawa et al., “RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial,” Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju020, 2014. View at Publisher · View at Google Scholar · View at Scopus
  196. P. O. Eser, J. P. Vanden Heuvel, J. Araujo, and J. T. Thompson, “Marine- and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation,” Molecular and Clinical Oncology, vol. 1, no. 3, pp. 444–452, 2013. View at Google Scholar
  197. S. A. Apte, D. A. Cavazos, K. A. Whelan, and L. A. Degraffenried, “A low dietary ratio of omega-6 to omega-3 fatty acids may delay progression of prostate cancer,” Nutrition and Cancer, vol. 65, no. 4, pp. 556–562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  198. P. Astorg, “Dietary n-6 and n-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence,” Cancer Causes & Control, vol. 15, no. 4, pp. 367–386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  199. M. D. Brown, C. A. Hart, E. Gazi, S. Bagley, and N. W. Clarke, “Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs,” British Journal of Cancer, vol. 94, no. 6, pp. 842–853, 2006. View at Publisher · View at Google Scholar · View at Scopus
  200. D. Ruan and S. P. So, “Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo,” Life Sciences, vol. 116, no. 1, pp. 43–50, 2014. View at Publisher · View at Google Scholar
  201. S. Larré, N. Tran, C. Fan et al., “PGE2 and LTB4 tissue levels in benign and cancerous prostates,” Prostaglandins and Other Lipid Mediators, vol. 87, no. 1–4, pp. 14–19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  202. T. M. Brasky, C. Till, E. White et al., “Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial,” The American Journal of Epidemiology, vol. 173, no. 12, pp. 1429–1439, 2011. View at Publisher · View at Google Scholar · View at Scopus
  203. R. Sosnowski and J. Zawistowski, “Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial,” European Urology, vol. 65, no. 5, p. 1012, 2014. View at Publisher · View at Google Scholar · View at Scopus
  204. K. Chow and D. G. Murphy, “Words of wisdom. Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial,” European Urology, vol. 64, no. 6, pp. 1015–1016, 2013. View at Google Scholar
  205. V. Kipnis, A. F. Subar, D. Midthune et al., “Structure of dietary measurement error: results of the OPEN biomarker study,” American Journal of Epidemiology, vol. 158, no. 1, pp. 14–21, 2003. View at Publisher · View at Google Scholar · View at Scopus
  206. D. J. Hunter, E. B. Rimm, F. M. Sacks et al., “Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men,” The American Journal of Epidemiology, vol. 135, no. 4, pp. 418–427, 1992. View at Google Scholar · View at Scopus
  207. Y. Kimura, “ω-3 PUFAs and colon cancer: epidemiological studies,” in Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer, G. Calviello and S. Serini, Eds., pp. 41–66, Springer, Dordrecht, The Netherlands, 2010. View at Google Scholar
  208. K. Wakai, Y. Ito, M. Kojima et al., “Intake frequency of fish and serum levels of long-chain n-3 fatty acids: a cross-sectional study within the Japan Collaborative Cohort Study,” Journal of Epidemiology, vol. 15, no. 6, pp. 211–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  209. L. K. Dennis, L. G. Snetselaar, B. J. Smith, R. E. Stewart, and M. E. C. Robbins, “Problems with the assessment of dietary fat in prostate cancer studies,” American Journal of Epidemiology, vol. 160, no. 5, pp. 436–444, 2004. View at Publisher · View at Google Scholar · View at Scopus
  210. L. Hodson, C. M. Skeaff, and B. A. Fielding, “Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake,” Progress in Lipid Research, vol. 47, no. 5, pp. 348–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  211. N. C. Øverby, L. Serra-Majem, and L. F. Andersen, “Dietary assessment methods on n-3 fatty acid intake: a systematic review,” The British Journal of Nutrition, vol. 102, supplement 1, pp. S56–S63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  212. L. Dahl, C. A. Mæland, and T. Bjørkkjær, “A short food frequency questionnaire to assess intake of seafood and n-3 supplements: validation with biomarkers,” Nutrition Journal, vol. 10, no. 1, article 127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  213. W. S. Harris and R. M. Thomas, “Biological variability of blood omega-3 biomarkers,” Clinical Biochemistry, vol. 43, no. 3, pp. 338–340, 2010. View at Publisher · View at Google Scholar · View at Scopus
  214. M. H. Davidson, J. Johnson, M. W. Rooney, M. L. Kyle, and D. F. Kling, “A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova compared to Lovaza in a pharmacokinetic single-dose evaluation) study,” Journal of Clinical Lipidology, vol. 6, no. 6, pp. 573–584, 2012. View at Publisher · View at Google Scholar · View at Scopus
  215. W. S. Harris, S. A. Varvel, J. V. Pottala, G. R. Warnick, and J. P. McConnell, “Comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: implications for clinical utility,” Journal of Clinical Lipidology, vol. 7, no. 5, pp. 433–440, 2013. View at Publisher · View at Google Scholar · View at Scopus
  216. E. Fasano, S. Serini, A. Cittadini, and G. Calviello, “Long-Chain n-3 PUFA against breast and prostate cancer: which are the appropriate doses for intervention studies in animals and humans?” Critical Reviews in Food Science and Nutrition, 2015. View at Publisher · View at Google Scholar
  217. E. J. Freireich, E. A. Gehan, D. P. Rall, L. H. Schmidt, and H. E. Skipper, “Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man,” Cancer Chemotherapy Reports, vol. 50, no. 4, pp. 219–244, 1966. View at Google Scholar · View at Scopus
  218. P. Bougnoux, N. Hajjaji, M. N. Ferrasson, B. Giraudeau, C. Couet, and O. Le Floch, “Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial,” British Journal of Cancer, vol. 101, no. 12, pp. 1978–1985, 2009. View at Publisher · View at Google Scholar · View at Scopus
  219. L. D. Yee, J. L. Lester, R. M. Cole et al., “ω-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition,” The American Journal of Clinical Nutrition, vol. 91, no. 5, pp. 1185–1194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  220. M. Yamashita, Y. Yamashita, T. Ando, J. Wakamiya, and S. Akiba, “Identification and determination of selenoneine, 2-selenyl-Nα, Nα, Nα-trimethyl-L-histidine, as the major organic selenium in blood cells in a fish-eating population on remote Japanese Islands,” Biological Trace Element Research, vol. 156, no. 1–3, pp. 36–44, 2013. View at Google Scholar
  221. J. Dort, N. Leblanc, J. Maltais-Giguère, B. Liaset, C. H. Côté, and H. Jacques, “Beneficial effects of cod protein on inflammatory cell accumulation in rat skeletal muscle after injury are driven by its high levels of arginine, glycine, taurine and lysine,” PLoS ONE, vol. 8, no. 10, Article ID e77274, 2013. View at Publisher · View at Google Scholar · View at Scopus
  222. R. Hosomi, M. Yoshida, and K. Fukunaga, “Seafood consumption and components for health,” Global Journal of Health Science, vol. 4, no. 3, pp. 72–86, 2012. View at Google Scholar · View at Scopus
  223. A. P. Simopoulos, “Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk,” Experimental Biology and Medicine, vol. 235, no. 7, pp. 785–795, 2010. View at Publisher · View at Google Scholar · View at Scopus
  224. J. P. Vanden Heuvel, “Nutrigenomics and nutrigenetics of ω3 polyunsaturated fatty acids,” Progress in Molecular Biology and Translational Science, vol. 108, pp. 75–112, 2012. View at Publisher · View at Google Scholar · View at Scopus
  225. M. Gago-Dominguez, J. E. Castelao, C.-L. Sun et al., “Marine n-3 fatty acid intake, glutathione S-transferase polymorphisms and breast cancer risk in post-menopausal Chinese women in Singapore,” Carcinogenesis, vol. 25, no. 11, pp. 2143–2147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  226. M. C. Stern, K. D. Siegmund, R. Corral, and R. W. Haile, “XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 3, pp. 609–615, 2005. View at Publisher · View at Google Scholar · View at Scopus
  227. E. M. Poole, J. Bigler, J. Whitton et al., “Genetic variability in prostaglandin synthesis, fish intake and risk of colorectal polyps,” Carcinogenesis, vol. 28, no. 6, pp. 1259–1263, 2007. View at Publisher · View at Google Scholar · View at Scopus
  228. E. M. Poole, L. Hsu, L. Xiao et al., “Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 2, pp. 547–557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  229. M. C. Stern, L. M. Butler, R. Corral et al., “Polyunsaturated fatty acids, DNA repair single nucleotide polymorphisms and colorectal cancer in the Singapore Chinese Health Study,” Journal of Nutrigenetics and Nutrigenomics, vol. 2, no. 6, pp. 273–279, 2010. View at Publisher · View at Google Scholar · View at Scopus
  230. S. R. Porenta, Y.-A. Ko, S. B. Gruber et al., “Interaction of fatty acid genotype and diet on changes in colonic fatty acids in a Mediterranean diet intervention study,” Cancer Prevention Research, vol. 6, no. 11, pp. 1212–1221, 2013. View at Publisher · View at Google Scholar · View at Scopus